Reset filter
Nyckelord
Visa mer Nyckelord
Innehållsförteckning
  1. 1. Klinisk studie
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
    1. 7.1. Anestesi
    1. 7.2. Dermatologi
    1. 7.3. HNO
    1. 7.4. Geriatrik
    1. 7.5. Gynekologi och obstetrik
    1. 7.6. Invärtes medicin
      1. Hematologi
      1. Infektionssjukdomar
      1. Kardiologi och angiologi
      1. Pneumologi
      1. Gastroenterologi
      1. Nefrologi
      1. Endokrinologi och ämnesomsättning
      1. Reumatologi
    1. 7.7. Neurologi
    1. 7.8. Oftalmologi
    1. 7.9. Palliativ medicin
    1. 7.10. Patologi och rättsmedicin
    1. 7.11. Pediatrik
    1. 7.12. Psykiatri och psykosomatik
    1. 7.13. Radiologi
    1. 7.14. Kirurgi
      1. Allmänkirurgi och bukkirurgi
      1. Neurokirurgi
      1. Plastikkirurgi
      1. Hjärt- och thoraxkirurgi
      1. Akutkirurgi och ortopedi
      1. Kärlkirurgi
    1. 7.15. Urologi
    1. 7.16. Odontologi samt mun-, käk och ansiktskirurgi
Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

2251 Sökresultat.
Relevans Bedömning Nya först Gamla först

Appendices TMP001 Multiple Sclerosis NCT02686788 - Appendices

- 2017-11-19 - 1 Formulär, 6 Item-grupper, 44 Dataelement, 1 Språk
Item-grupper: medical history, Comorbidity, Medication, Exacerbation of multiple sclerosis, Adverse Events, Follow- up
Study Part: Appendices. TMP001 in Relapsing-remitting Multiple Sclerosis: A Multicentre Open, Baseline-controlled Phase IIa Clinical Trial.

Eligibility Multiple Sclerosis Tysabri NCT00027300 - Admission Eligibility Multiple Sclerosis Tysabri NCT00027300

- 2017-01-27 - 1 Formulär, 4 Item-grupper, 26 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria, Exclusion Criteria, Exclusion Criteria
The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS.

Eligibility Multiple Sclerosis NCT00845338

- 2017-08-12 - 1 Formulär, 2 Item-grupper, 19 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity; ODM derived from: https://clinicaltrials.gov/show/NCT00845338

Eligibility Multiple Sclerosis NCT02499900

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®; ODM derived from: https://clinicaltrials.gov/show/NCT02499900

Eligibility Multiple Sclerosis NCT02428231

- 2019-05-18 - 1 Formulär, 1 Item-grupp, 11 Dataelement, 1 Språk
Item-grupp: Criteria
Tecfidera Slow-titration Study; ODM derived from: https://clinicaltrials.gov/show/NCT02428231

Eligibility Multiple Sclerosis NCT02474134

- 2019-05-18 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Comparison Study of PF530 and Betaferon in Healthy Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT02474134

Eligibility Multiple Sclerosis NCT02297932

- 2019-05-16 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes; ODM derived from: https://clinicaltrials.gov/show/NCT02297932

Eligibility Multiple Sclerosis NCT02201849

- 2019-05-16 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults; ODM derived from: https://clinicaltrials.gov/show/NCT02201849

Eligibility Multiple Sclerosis NCT02386566

- 2019-05-17 - 1 Formulär, 1 Item-grupp, 11 Dataelement, 1 Språk
Item-grupp: Criteria
Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab; ODM derived from: https://clinicaltrials.gov/show/NCT02386566

Eligibility Multiple Sclerosis NCT01829776

- 2019-01-07 - 1 Formulär, 2 Item-grupper, 9 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Pilot Study of Free From Falls Program in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01829776

Eligibility Multiple Sclerosis NCT02326935

- 2019-05-17 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02326935

Eligibility Multiple Sclerosis NCT02034188

- 2019-05-15 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02034188

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial